• CVS Health posted its Q2 2026 earnings call transcript from Aug. 5, attended by CEO J. David Joyner, CFO Brian Newman, and leaders of Aetna and Health Services.
• Adjusted EPS came in at 2.58 on revenue above 106 billion; adjusted operating income reached 5.2 billion, with year-to-date operating cash flow at 10.6 billion.
• Full-year adjusted EPS guidance lifted by 0.60 to 7.90-8.10; cash flow from operations outlook raised to at least 11.5 billion; revenue expected at least 414 billion.
• Management flagged 2027 headwinds in Caremark from 340B pressure and expected membership declines; preliminary view of adjusted EPS at least 8.44.
• CVS outlined GLP-1 cash-pay push: MinuteClinic virtual weight management visits at 29; eligible patients can access therapies for as little as 149.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Health Corporation published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.